GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ultragenyx Pharmaceutical Inc (LTS:0LIF) » Definitions » Price-to-Tangible-Book

Ultragenyx Pharmaceutical (LTS:0LIF) Price-to-Tangible-Book : 97.61 (As of Apr. 17, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Ultragenyx Pharmaceutical Price-to-Tangible-Book?

As of today (2025-04-17), Ultragenyx Pharmaceutical's share price is $34.36. Ultragenyx Pharmaceutical's Tangible Book per Share of Dec. 2024 for the quarter that ended in Dec. 2024 was $0.35. Hence, Ultragenyx Pharmaceutical's Price to Tangible Book Ratio of today is 97.61.

The historical rank and industry rank for Ultragenyx Pharmaceutical's Price-to-Tangible-Book or its related term are showing as below:

LTS:0LIF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 5.08   Med: 8.83   Max: 119.52
Current: 101.06

During the past 13 years, Ultragenyx Pharmaceutical's highest Price to Tangible Book Ratio was 119.52. The lowest was 5.08. And the median was 8.83.

LTS:0LIF's Price-to-Tangible-Book is ranked worse than
98.92% of 1205 companies
in the Biotechnology industry
Industry Median: 2.41 vs LTS:0LIF: 101.06

A closely related ratio is called PB Ratio. As of today, Ultragenyx Pharmaceutical's share price is $34.36. Ultragenyx Pharmaceutical's Book Value per Sharefor the quarter that ended in Dec. 2024 was $2.76. Hence, Ultragenyx Pharmaceutical's P/B Ratio of today is 12.45.


Ultragenyx Pharmaceutical Price-to-Tangible-Book Historical Data

The historical data trend for Ultragenyx Pharmaceutical's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ultragenyx Pharmaceutical Price-to-Tangible-Book Chart

Ultragenyx Pharmaceutical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.21 7.68 21.93 60.97 118.17

Ultragenyx Pharmaceutical Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.97 - 17.11 37.51 118.17

Competitive Comparison of Ultragenyx Pharmaceutical's Price-to-Tangible-Book

For the Biotechnology subindustry, Ultragenyx Pharmaceutical's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ultragenyx Pharmaceutical's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ultragenyx Pharmaceutical's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Ultragenyx Pharmaceutical's Price-to-Tangible-Book falls into.


;
;

Ultragenyx Pharmaceutical Price-to-Tangible-Book Calculation

Ultragenyx Pharmaceutical's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2024 )
=34.36/0.352
=97.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Ultragenyx Pharmaceutical Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Ultragenyx Pharmaceutical's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Ultragenyx Pharmaceutical Business Description

Traded in Other Exchanges
Address
60 Leveroni Court, Novato, CA, USA, 94949
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.

Ultragenyx Pharmaceutical Headlines

No Headlines